Suboptimal use of diabetes management technology in children and adolescents with T1D
A Hong Kong territory-wide study has found that despite improved glycaemic outcomes and device reimbursement, use of continuous glucose monitoring systems (CGMS) and/or automated insulin delivery (AID) systems remains suboptimal in patients ≤18 years old with type 1 diabetes (T1D), particularly among adolescents, alluding to barriers beyond cost.
